Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term Outlook
10:06am, Wednesday, 05'th Feb 2025
GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion.
GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion
09:04am, Wednesday, 05'th Feb 2025
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales. The post GSK Surges 7% After Bumping Its 2031 Outlook To North
GSK (GSK) Tops Q4 Earnings and Revenue Estimates
08:06am, Wednesday, 05'th Feb 2025
GSK (GSK) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.72 per share a year ago.
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
08:05am, Wednesday, 05'th Feb 2025
Wednesday, GSK Plc GSK reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The analysts estimated sales of $9.58 bil
GSK shares surge around 6% as drugmaker raises sales target and boosts dividends
04:38am, Wednesday, 05'th Feb 2025
Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and reported strong financial results for 2024. The stock climbed 5.9% in early tra
GSK shares rise 5% as it navigates vaccines woes to upgrade sales target
04:28am, Wednesday, 05'th Feb 2025
GSK PLC (LSE:GSK, NYSE:GSK) shares climbed 5% in early trading on Wednesday after the drugs giant appeared to shrug off vaccine-related woes and mollified the City by raising its long-term sales targ
GSK upgrades long-term sales target; but Arexvy's struggles are confirmed
02:44am, Wednesday, 05'th Feb 2025
GSK PLC (LSE:GSK, NYSE:GSK) has raised its long-term revenue forecast, now expecting sales to exceed £40 billion by 2031, up from its previous £38 billion target. The upgrade comes after what the c
GSK beats Q4 earnings estimates, lifts 2031 sales target
02:17am, Wednesday, 05'th Feb 2025
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines division.
Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against GSK plc
08:40pm, Tuesday, 04'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action lawsuit in the U.S. District Court for the Eastern Dis
AstraZeneca and GSK put spotlight on pharma as results loom
10:46am, Thursday, 30'th Jan 2025
AstraZeneca PLC and GSK PLC will bring the pharmaceutical sector into the spotlight when both report next week. For AstraZeneca, full-year figures on Thursday, February 6 come after its shares have re
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
11:05am, Wednesday, 29'th Jan 2025
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory Diseases
09:40am, Wednesday, 29'th Jan 2025
If approved, GSK's depemokimab will be the first ultra-long-acting biologic that requires only one dose every six months.
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
08:00am, Wednesday, 29'th Jan 2025
Biotech stocks will need to brace for political "games" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS. The post The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senat
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company A
GSK to explore cancer vaccines with Oxford University in £50mln deal
04:47am, Monday, 27'th Jan 2025
GSK PLC has unveiled plans to pour £50 million into research with Oxford University over vaccines to prevent some types of cancer. A GSK-Oxford Cancer Immuno-Prevention Programme would investigate ho
